INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (INO)

Q: What does CUSIP 45773H409 represent in this 13F holders report?

CUSIP 45773H409 is the security identifier for INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q4 2024?

100 institutional investors reported INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q4 2024. Use the holders table for investor-level position and value details.

CUSIP: 45773H409

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 13,346,624
Total 13F value: $24,424,740
Share change: +4,673,304
Put/Call ratio: 23%
SEC-reported price per share: $1.83
Number of holders: 100
Value change: +$7,463,553
Number of buys: 54
Number of sells: 32
Shares outstanding: 85,714,275

Security key

45773H409

Report period

Q4 2024

Institutions

100

Top holders

INO full security history Ownership snapshot Full 13F holder table INOVIO PHARMACEUTICALS, INC. SEC filings INOVIO PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

BlackRock, Inc.

Comparable rows

15/15

Latest evidence

30 Sep 2024

13F Lead comparable stake: 2.2% Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 2.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.

Comparable ownership Top 5

BlackRock, Inc. 2.2%

Deep Track Capital, LP 2.1%

VANGUARD GROUP INC 2.1%

GEODE CAPITAL MANAGEMENT, LLC 0.73%

STATE STREET CORP 0.57%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock, Inc.	13F Company 13F	2.2%	$10,898,739 1,885,595 shares	—	30 Sep 2024
Deep Track Capital, LP	13F Company 13F	2.1%	$10,429,235 1,804,366 shares	—	30 Sep 2024
VANGUARD GROUP INC	13F Company 13F	2.1%	$10,392,209 1,797,960 shares	—	30 Sep 2024
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.73%	$3,593,609 621,631 shares	—	30 Sep 2024
STATE STREET CORP	13F Company 13F	0.57%	$2,836,026 490,662 shares	—	30 Sep 2024
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.39%	$1,913,561 331,066 shares	—	30 Sep 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

100

13,346,624

Rows available

100

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

100

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %